Suppr超能文献

人类N-乙酰转移酶1编码区单核苷酸多态性的功能效应

Functional effects of single nucleotide polymorphisms in the coding region of human N-acetyltransferase 1.

作者信息

Zhu Y, Hein D W

机构信息

Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40292, USA.

出版信息

Pharmacogenomics J. 2008 Oct;8(5):339-48. doi: 10.1038/sj.tpj.6500483. Epub 2007 Oct 2.

Abstract

Genetic variants of human N-acetyltransferase 1 (NAT1) are associated with cancer and birth defects. N- and O-acetyltransferase catalytic activities, Michaelis-Menten kinetic constants (K(m) and V(max)) and steady-state expression levels of NAT1-specific mRNA and protein were determined for the reference NAT14 and variant human NAT1 haplotypes possessing single nucleotide polymorphisms (SNPs) in the open reading frame. Although none of the SNPs caused a significant effect on steady-state levels of NAT1-specific mRNA, C97T(R33stop), C190T(R64W), C559T (R187stop) and A752T(D251V) each reduced NAT1 protein level and/or N- and O-acetyltransferase catalytic activities to levels below detection. G560A(R187Q) substantially reduced NAT1 protein level and catalytic activities and increased substrate K(m). The G445A(V149I), G459A(synonymous) and T640G(S214A) haplotype present in NAT111 significantly (P<0.05) increased NAT1 protein level and catalytic activity. Neither T21G(synonymous), T402C(synonymous), A613G(M205V), T777C(synonymous), G781A(E261K) nor A787G(I263V) significantly affected K(m), catalytic activity, mRNA or protein level. These results suggest heterogeneity among slow NAT1 acetylator phenotypes.

摘要

人类N-乙酰基转移酶1(NAT1)的基因变异与癌症和出生缺陷有关。针对参考NAT14以及在开放阅读框中具有单核苷酸多态性(SNP)的变异人类NAT1单倍型,测定了N-和O-乙酰基转移酶的催化活性、米氏动力学常数(K(m)和V(max))以及NAT1特异性mRNA和蛋白质的稳态表达水平。尽管没有一个SNP对NAT1特异性mRNA的稳态水平产生显著影响,但C97T(R33stop)、C190T(R64W)、C559T(R187stop)和A752T(D251V)各自将NAT1蛋白质水平和/或N-和O-乙酰基转移酶催化活性降低至检测水平以下。G560A(R187Q)大幅降低了NAT1蛋白质水平和催化活性,并增加了底物K(m)。NAT111中存在的G445A(V149I)、G459A(同义突变)和T640G(S214A)单倍型显著(P<0.05)增加了NAT1蛋白质水平和催化活性。T21G(同义突变)、T402C(同义突变)、A613G(M205V)、T777C(同义突变)、G781A(E261K)和A787G(I263V)均未对K(m)、催化活性、mRNA或蛋白质水平产生显著影响。这些结果表明慢NAT1乙酰化酶表型之间存在异质性。

相似文献

1
Functional effects of single nucleotide polymorphisms in the coding region of human N-acetyltransferase 1.
Pharmacogenomics J. 2008 Oct;8(5):339-48. doi: 10.1038/sj.tpj.6500483. Epub 2007 Oct 2.
2
Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1.
Drug Metab Rev. 2008;40(1):169-84. doi: 10.1080/03602530701852917.
4
Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regions.
Birth Defects Res A Clin Mol Teratol. 2011 Feb;91(2):77-84. doi: 10.1002/bdra.20763. Epub 2011 Feb 2.
5
Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas.
Pharmacogenetics. 1998 Jun;8(3):269-81. doi: 10.1097/00008571-199806000-00009.
7
Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependent.
Drug Metab Dispos. 2012 Jan;40(1):198-204. doi: 10.1124/dmd.111.041855. Epub 2011 Oct 18.
9
Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations.
Pharmacogenetics. 1998 Feb;8(1):67-72. doi: 10.1097/00008571-199802000-00009.

引用本文的文献

1
Bioactivation, Mutagenicity, DNA Damage, and Oxidative Stress Induced by 3,4-Dimethylaniline.
Biomolecules. 2024 Dec 7;14(12):1562. doi: 10.3390/biom14121562.
2
Effects of dose and human N-acetyltransferase 1 genetic polymorphism in benzidine metabolism and genotoxicity.
Arch Toxicol. 2023 Jun;97(6):1765-1772. doi: 10.1007/s00204-023-03497-1. Epub 2023 Apr 25.
3
Acetyl coenzyme A kinetic studies on -acetylation of environmental carcinogens by human -acetyltransferase 1 and its variant.
Front Pharmacol. 2022 Oct 28;13:931323. doi: 10.3389/fphar.2022.931323. eCollection 2022.
4
Human -Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and -Hydroxy-Arylamine Carcinogens.
Front Pharmacol. 2022 Feb 25;13:821133. doi: 10.3389/fphar.2022.821133. eCollection 2022.
6
Case Study 10: A Case to Investigate Acetyl Transferase Kinetics.
Methods Mol Biol. 2021;2342:781-808. doi: 10.1007/978-1-0716-1554-6_29.
9
Humans and Chimpanzees Display Opposite Patterns of Diversity in Genes.
G3 (Bethesda). 2019 Jul 9;9(7):2199-2224. doi: 10.1534/g3.119.400223.
10
Functional expression of human arylamine N-acetyltransferase NAT1*10 and NAT1*11 alleles: a mini review.
Pharmacogenet Genomics. 2018 Oct;28(10):238-244. doi: 10.1097/FPC.0000000000000350.

本文引用的文献

1
Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2.
Pharmacogenet Genomics. 2007 Jan;17(1):37-45. doi: 10.1097/01.fpc.0000236325.73186.2c.
2
A "silent" polymorphism in the MDR1 gene changes substrate specificity.
Science. 2007 Jan 26;315(5811):525-8. doi: 10.1126/science.1135308. Epub 2006 Dec 21.
4
Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.
Pharmacogenet Genomics. 2006 Jul;16(7):515-25. doi: 10.1097/01.fpc.0000215066.29342.26.
5
Loss of function polymorphisms in NAT1 protect against spina bifida.
Hum Genet. 2006 Aug;120(1):52-7. doi: 10.1007/s00439-006-0181-6. Epub 2006 May 6.
6
N-Acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population.
Clin Chim Acta. 2006 Sep;371(1-2):85-91. doi: 10.1016/j.cca.2006.02.025. Epub 2006 Feb 28.
8
Arylamine N-acetyltransferases: what we learn from genes and genomes.
Drug Metab Rev. 2005;37(3):511-64. doi: 10.1080/03602530500251204.
10
The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida.
Birth Defects Res A Clin Mol Teratol. 2005 Jul;73(7):512-6. doi: 10.1002/bdra.20143.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验